59:12
Dr. Pamela Bjorkman: Neutralizing Antibodies Against Coronaviruses
01:03:50
Dr. Daniela Weiskopf and Dr. Alessandro Sette Lab Meeting of La Jolla Institute of Immunology
57:54
Dr. Douglas Nixon: COVID-19 – Can Old Vaccines Have New Tricks?
57:16
Dr. Robert Seder: Protection in mRNA-1273-Immunized Nonhuman Primates Against the B.1.351 Variant
59:04
Dr. Laura Walker: Generation of Broad and Potent Neutralizing Antibodies to Speed Pandemic Responses
57:17
Dr. Nir Barzilai: Aging Later Through This Pandemic and the Next
58:41
Dr. Petter Brodin: Systems-level blood immunomonitoring study of SARS-CoV-2 patients
59:29
Dr. Penny Moore: SARS-CoV-2 Infection and Vaccination in South Africa
51:26
Dr. Darragh Duffy: Understanding Immune Variability to Infection with SARS-CoV-2
59:30
Dr. Sean N. Tucker: Vaxart's Oral Covid-19 Vaccine. Hold the Ice (and the Needles)
01:03:24
Dr. Christos Kyratsous: Selection, testing of a fully-human antibody cocktail against SARS-CoV-2
01:04:29
Dr. Barney S. Graham: Rapid COVID-19 Vaccine Development Enabled by Prototype Pathogen Preparedness
59:58
Dr. Menno van Zelm: B cell memory to SARS-CoV2 Nucleocapsid and Spike proteins in COVID-19 disease
58:05
Dr. Eleanor N. Fish: Global Virus Outbreaks – Interferons as 1st Responders
01:01:32
Dr Kizzmekia Corbett: SARS-CoV-2 mRNA vaccine development enabled by prototype pathogen preparedness
01:02:09
Dr. Davide Corti: Tackling COVID-19 with Human Neutralizing Antibodies
56:27
Dr. Emanuele Andreano: Extremely potent human monoclonal antibodies against SARS-CoV-2
01:03:12
Dr. Sarah Gilbert: Rapid preclinical and clinical development of ChAdOx1 nCoV-19
01:00:45
Dr. John Wherry: Deep Immune Profiling in SARS-CoV-2 Patients
59:56
Dr. Michael Farzan: ACE2, the SARS-CoV-2 S protein, and better RBD-based vaccines
02:04:03
The 2020 Michelson Prizes
59:42
Dr. Dan Barouch: COVID-19 Vaccine Development
02:19
HVP Michelson Prizes: Michael Birnbaum
02:34
HVP Michelson Prizes: Danika Hill
01:07:10
Dr. Galit Alter: Using Systems Serology to Define Antibody Responses to SARS-CoV-2
01:03:00
Dr. Jardine & Dr. Rogers: Rapid isolation of potent SARS-CoV-2 neutralizing antibodies & protection
01:06:27
Dr. Bette Korber: Spike mutations and recombination in SARS-CoV-2 pandemic viruses
01:02:25
Prof. Shane Crotty: T cell responses to SARS-CoV-2
59:40
Dr. David Weiner: Synthetic DNA vaccines as a rapid response to infectious disease outbreaks
56:40
Dr. James E. Crowe, Jr: Human Monoclonal Antibodies for SARS-CoV-2
02:53
Why the Human Immune System?
02:06
Michelson Prize Winner Avinash Das Sahu
01:57
Michelson Prize Winner Kamal Mandal
02:17
Michelson Prize Winner Murad Mamedov
44:32
Helder Nakaya - Influenza Webinar Series - May 2019
02:11
Moving Toward Immunology 2.0
49:24
Seema Lakdawala - Influenza Webinar Series - April 2019
01:07
Creating Health Innovations Through Teamwork
56:32
Adrian McDermott - Influenza Webinar Series - March 2019
48:51
Aly Khan - Influenza Webinar Series - February 2019
22:23
Klaus Ley - Translating an Atherosclerosis Vaccine to Clinical Trials
25:47
Scott Fraser - Multiplex and Multimodal Molecular Imaging of Cells In Their Natural Contexts
16:02
Welcome Session
30:06
John Schiller - Moving Toward Single-Shot Subunit Vaccines
34:33
Richard H. Scheuermann - Machine Learning and Single Cell Genomics...
28:02
Arnaud Marchant - Immunobiology of Maternal Immunization
24:53
Neil King - Design of Self Assembling Protein Nanomaterials for Next-Generation Vaccines
24:36
Laura Mackay, Michelson Prize Winner
22:26
Ansuman Satpathy, Michelson Prize Winner
31:20
James E Crowe - The Human Immunome
21:20
Nathalie Garcon - Adjuvants Today and Tomorrow, For Whom and For What
25:25
Neeha Zaidi - New Approaches to Cancer Vaccines
31:40
William Schief - Germline Targeting and Structure Assisted Vaccine Discovery for Infectious Diseases
28:00
Ajay Verma Vaccines - Treating Neurodegenerative Disase
25:25
Mark M. Davis - The Potential
18:56
Patricia Illing, Michelson Prize Winner
24:04
Tobias Kollman - The Rules of Immunity
01:41
The Genesis of the Human Vaccines Project
01:00:00
Scott Hensley - Influenza Webinar Series - October 2018
01:00:25
James Crowe - Influenza Webinar Series - August 2018
X
About
The Human Immunome Project (HIP) is a global nonprofit organization dedicated to decoding and modeling the immune system.
The human immune system is one of the most complex systems in the world, and one of its most important. It determines whether we survive infancy, which diseases we get, how we age, and how long we’ll live. Understanding it is the key to fighting disease and improving health for all. Yet its complexity has limited our ability to tap into its potential—until now.
Recent advances in AI provide the tools to rapidly process the trillions of datapoints required to model the immune system, understand how it varies across individuals, and develop targeted approaches to elongating healthspans.
To achieve this transformative goal, we generate diverse immunological datasets at scale and build publicly available AI models of the immune system to accelerate medical research and drug discovery, improve health, and decrease healthcare costs worldwide.
Tags